Screening for cell migration inhibitors via automated microscopy reveals a rho-kinase inhibitor

被引:108
|
作者
Yarrow, JC [1 ]
Totsukawa, G
Charras, GT
Mitchison, TJ
机构
[1] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Inst Chem & Cell Biol, Boston, MA 02115 USA
[3] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA
来源
CHEMISTRY & BIOLOGY | 2005年 / 12卷 / 03期
关键词
D O I
10.1016/j.chembiol.2005.01.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Small-molecule kinase inhibitors are predominantly discovered in pure protein assays. We have discovered an inhibitor of Rho-kinase (ROCK) through an image-based, high-throughput screen of cell monolayer wound healing. Using automated microscopy, we screened a library of 16,000 compounds finding many that affected cell migration or cell morphology as well as compounds that blocked mitotic progression. We tested 200 compounds in a series of subassays and chose one, 3-(4-pyridyl)indole (Rockout), for more detailed characterization. Rockout inhibits blebbing and causes dissolution of actin stress fibers, phenocopying Rho-kinase inhibitors. Testing Rho-kinase activity in vitro, Rockout inhibits with an IC50 of 25 mu M (5-fold less potent than Y-27632) but has a similar specificity profile. We also profile the wound healing assay with a library of compounds with known bioactivities, revealing multiple pathways involved in the biology.
引用
收藏
页码:385 / 395
页数:11
相关论文
共 50 条
  • [21] Rho-kinase Inhibitor Assisted Cell Therapy for the Treatment of Corneal Endothelial Decompensation
    Okumura, Naoki
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2023, 39 (08) : A14 - A14
  • [22] The Rho-kinase inhibitor inhibits proliferation and metastasis of small cell lung cancer
    Yang, Xueying
    Di, Jing
    Zhang, Yang
    Zhang, Suning
    Lu, Jibin
    Liu, Jun
    Shi, Wenjun
    BIOMEDICINE & PHARMACOTHERAPY, 2012, 66 (03) : 221 - 227
  • [23] Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor
    Yasuaki Hata
    Muneki Miura
    Shintaro Nakao
    Shuhei Kawahara
    Takeshi Kita
    Tatsuro Ishibashi
    Japanese Journal of Ophthalmology, 2008, 52 : 16 - 23
  • [24] Progress of the study of Rho-kinase and future perspective of the inhibitor
    Tawara, Shunsuke
    Shimokawa, Hiroaki
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 (03): : 501 - 514
  • [25] Effects of the Rho-Kinase Inhibitor, Fasudil, on Pulmonary Hypertension
    Odagiri, Keiichi
    Watanabe, Hiroshi
    CIRCULATION JOURNAL, 2015, 79 (06) : 1213 - 1214
  • [26] Role of Rho-kinase and its inhibitors in pulmonary hypertension
    Duong-Quy, Sy
    Bei, Yihua
    Liu, Zhongmin
    Dinh-Xuan, Anh Tuan
    PHARMACOLOGY & THERAPEUTICS, 2013, 137 (03) : 352 - 364
  • [27] Rho-kinase inhibitors show promise in pulmonary hypertension
    Doggrell, SA
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (09) : 1157 - 1159
  • [28] Rho-Kinase Inhibitors as Emerging Targets for Glaucoma Therapy
    Wang, Jun
    Wang, Hanke
    Dang, Yalong
    OPHTHALMOLOGY AND THERAPY, 2023, 12 (06) : 2943 - 2957
  • [29] Development of specific Rho-kinase inhibitors and their clinical application
    Tamura, M
    Nakao, H
    Yoshizaki, H
    Shiratsuchi, M
    Shigyo, H
    Yamada, H
    Ozawa, T
    Totsuka, J
    Hidaka, H
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2005, 1754 (1-2): : 245 - 252
  • [30] Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor
    Hata, Yasuaki
    Miura, Muneki
    Nakao, Shintaro
    Kawahara, Shuhei
    Kita, Takeshi
    Ishibashi, Tatsuro
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2008, 52 (01) : 16 - 23